differentiated antibiotics

Cempra Reports Third Quarter 2014 Financial Results and Provides Corporate Update

CHAPEL HILL, N.C., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the quarter and nine months ended September 30, 2014 and provided an update on recent corporate developments. 

 

Cempra to Report Third Quarter 2014 Financial Results and Host Webcast and Conference Call on October 29, 2014

CHAPEL HILL, N.C., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that it will report third quarter 2014 financial results after the close of U.S. financial markets on October 29, 2014.